Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded Last action
- Contract number
- SPE2DR26FRRE8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,176
Award facts
- Contract value 100% obligated
- $16,176.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,176.00 to DMS Pharmaceutical Group Inc. for the supply of EYLEA HD 8 mg/0.07 ml vials on December 1, 2025. This firm fixed-price delivery order is scheduled for completion by December 22, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy authorized through December 31, 2036. The IDC, valued at $499,999,999, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor supplying diverse pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. EYLEA HD, an ophthalmic biologic agent, falls within the company's established portfolio of specialty pharmaceuticals and supports the military healthcare system's recurring medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FRRE8?
SPE2DR26FRRE8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FRRE8 worth?
The government has obligated $16,176 on SPE2DR26FRRE8.
Is contract SPE2DR26FRRE8 an order under another contract?
Yes. SPE2DR26FRRE8 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRE8 competed?
The extent of competition for SPE2DR26FRRE8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award